Bayer announces Phase III CHICO study of Nifurtimox to treat Chagas disease

Bayer has announced a Phase III CHICO study of Nifurtimox to treat children of all age groups with Chagas disease.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news